Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -126,036 | -110,228 | -204,149 | -154,383 | -155,177 |
| Depreciation Amortization | 119,539 | 58,389 | 207,229 | 153,057 | 100,803 |
| Income taxes - deferred | 2,225 | 1,797 | -955 | -279 | 672 |
| Accounts receivable | -60,901 | -37,536 | -43,416 | -40,306 | -20,492 |
| Accounts payable and accrued liabilities | -17,865 | -53,515 | 82,750 | 51,084 | 48,754 |
| Other Working Capital | -78,967 | -108,209 | -342 | -26,997 | -2,425 |
| Other Operating Activity | 186,759 | 166,991 | 115,002 | 104,394 | 90,074 |
| Operating Cash Flow | $24,754 | $-82,311 | $156,119 | $86,570 | $62,209 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -244,037 | -133,347 | 223,302 | 252,958 | 220,169 |
| PPE Investments | -73,515 | -37,649 | -124,690 | -89,268 | -64,081 |
| Net Acquisitions | N/A | N/A | -52,413 | -50,000 | N/A |
| Purchase Of Investment | -810 | N/A | -16,564 | -6,290 | -6,173 |
| Sale Of Investment | N/A | N/A | 19,794 | 9,296 | N/A |
| Other Investing Activity | -205 | -442 | 250 | -250 | -500 |
| Investing Cash Flow | $-318,567 | $-171,438 | $49,679 | $116,446 | $149,415 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 266,750 | N/A | 137,976 | 137,976 | 137,976 |
| Common Stock Issued | 18,037 | -1,408 | 31,541 | 19,237 | 18,160 |
| Other Financing Activity | -63,186 | -1,594 | -9,751 | -7,484 | -6,499 |
| Financing Cash Flow | $221,601 | $-3,002 | $159,766 | $149,729 | $149,637 |
| Exchange Rate Effect | -1,446 | -1,140 | 1,321 | -626 | 609 |
| Beginning Cash Position | 609,675 | 609,675 | 242,790 | 242,790 | 242,790 |
| End Cash Position | 536,017 | 351,784 | 609,675 | 594,909 | 604,660 |
| Net Cash Flow | $-73,658 | $-257,891 | $366,885 | $352,119 | $361,870 |
| Free Cash Flow | |||||
| Operating Cash Flow | 24,754 | -82,311 | 156,119 | 86,570 | 62,209 |
| Capital Expenditure | -73,515 | -37,649 | -124,690 | -89,268 | -64,081 |
| Free Cash Flow | -48,761 | -119,960 | 31,429 | -2,698 | -1,872 |